Patient and Provider Perspectives on Benefits and Harms of Continuing, Tapering, and Discontinuing Long-Term Opioid Therapy

被引:9
|
作者
Nevedal, Andrea L. [1 ]
Timko, Christine [2 ,3 ]
Lor, Mai Chee [2 ]
Hoggatt, Katherine J. [4 ,5 ]
机构
[1] VA Ctr Clin Management Res, Dept Vet Affairs Hlth Care Syst, Ann Arbor, MI 48105 USA
[2] Ctr Innovat Implementat, Dept Vet Affairs Hlth Care Syst, Palo Alto, CA USA
[3] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
[4] San Francisco VA Hlth Care Syst, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
opioids; tapering; veterans; patients; providers; qualitative methods; long-term opioid therapy; COMPLEMENTARY;
D O I
10.1007/s11606-022-07880-z
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Given efforts to taper patients off long-term opioid therapy (LTOT) because of known harms, it is important to understand if patients and providers align in LTOT treatment goals. Objective To investigate patient and provider perceptions about the harms and benefits of continuing and discontinuing LTOT. Design Qualitative study Participants Patients and providers with experiences with LTOT for pain in two Veterans Health Affairs regions. Approach We conducted semi-structured interviews and analyzed data using rapid qualitative analysis to describe patient and provider preferences about LTOT continuation and discontinuation and non-opioid pain treatments. Key Results Participants (n=43) included 28/67 patients and 15/17 providers. When discussing continuing LTOT, patients emphasized the benefits outweighed the harms, whereas providers emphasized the harms. Participants agreed on the benefits of continuing LTOT for improved physical functioning. Provider-reported benefits of continuing LTOT included maintaining the status quo for patients without opioid alternatives or who were at risk for illicit drug use. Participants were aligned regarding the harms of negative side-effects (e.g., constipation) from continued LTOT. In contrast, when discussing LTOT tapering and discontinuation, providers underscored how benefits outweighed the harms, citing patients' improved well-being and pain management with tapering or alternatives. Patients did not foresee benefits to potential LTOT tapers or discontinuation and were worried about pain management in the absence of LTOT. When discussing non-opioid pain treatments, participants emphasized that they were adjunctive to opioid therapy rather than a replacement (except for cannabis). Providers described the importance of mental health services to manage pain, which differed from patients who focused on treatments to improve strength and mobility and reduce pain. Conclusions Patients emphasized the benefits of continuing LTOT for pain management and well-being, which differed from providers' emphasis on the benefits of discontinuing LTOT. Patient and provider differences are important for informing patient-centered care and decisions around continuing, tapering, or discontinuing LTOT.
引用
收藏
页码:1802 / 1811
页数:10
相关论文
共 50 条
  • [21] When harms outweigh benefits of long-term opioid therapy for pain: Need for a new diagnostic entity, research and improved treatments
    Becker, William C.
    Frank, Joseph W.
    Edmond, Sara N.
    Starrels, Joanna L.
    ADDICTION, 2024, 119 (01) : 4 - 5
  • [22] Arguments for and Against a New Diagnostic Entity for Patients With Chronic Pain on Long-Term Opioid Therapy for Whom Harms Outweigh Benefits
    Edmond, Sara N.
    Snow, Jennifer L.
    Pomeranz, Jamie
    Van Cleve, Raymond
    Becker, William C.
    JOURNAL OF PAIN, 2022, 23 (06): : 958 - 966
  • [23] Long-term outcome with clozapine: comparison of patients continuing and discontinuing treatment
    Laker, MK
    Duffett, RS
    Cookson, JC
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 (02) : 75 - 78
  • [24] HHS Guide for Tapering or Stopping Long-term Opioid Use
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (20): : 1947 - 1947
  • [25] LONG-TERM OPIOID THERAPY
    Manchikanti, Laxmaiah
    Benyamin, Ramsin M.
    PAIN PRACTICE, 2009, 9 (02) : 164 - 164
  • [26] Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review
    Katherine Mackey
    Johanna Anderson
    Donald Bourne
    Emilie Chen
    Kim Peterson
    Journal of General Internal Medicine, 2020, 35 : 935 - 944
  • [27] Tapering Long-term Opioid Therapy in Chronic Noncancer Pain: Evidence and Recommendations for Everyday Practice
    Berna, Chantal
    Kulich, Ronald J.
    Rathmell, James P.
    MAYO CLINIC PROCEEDINGS, 2015, 90 (06) : 828 - 842
  • [28] Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review
    Mackey, Katherine
    Anderson, Johanna
    Bourne, Donald
    Chen, Emilie
    Peterson, Kim
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 3) : 935 - 944
  • [29] Long-term antidepressant use: patient perspectives of benefits and adverse effects
    Cartwright, Claire
    Gibson, Kerry
    Read, John
    Cowan, Ondria
    Dehar, Tamsin
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 1401 - 1407
  • [30] Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study
    Hayes, Corey J.
    Krebs, Erin E.
    Brown, Joshua
    Li, Chenghui
    Hudson, Teresa
    Martin, Bradley C.
    JOURNAL OF PAIN, 2021, 22 (12): : 1709 - 1721